NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Chembio Diagnostics, Inc. (NASDAQ: CEMI) to Biosynex SA for $0.45 per share is fair to ...
Thinly traded nano cap Chembio Diagnostics (CEMI-13.1%) is down on modestly higher volume, only 148K shares, on the heels of an update on its U.S. marketing application for its DPP HIV-Syphilis Assay ...
Access detailed historical stock prices, including daily closing prices, for CEMI:CA. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results